Cytomegalovirus mismatch after heart transplantation: Impact of antiviral prophylaxis and intravenous hyperimmune globulin-Reference-Cited by-同舟云学术

Cytomegalovirus mismatch after heart transplantation: Impact of antiviral prophylaxis and intravenous hyperimmune globulin

Published:2021-09-15 Issue:4 Volume:9 Page:1554-1562
ISSN:2050-4527
Container-title:Immunity, Inflammation and Disease
language:en
Short-container-title:Immun Inflamm Dis

Author:

Immohr Moritz B.¹^ORCID,Akhyari Payam¹^ORCID,Böttger Charlotte¹,Mehdiani Arash¹,Dalyanoglu Hannan¹,Westenfeld Ralf²,Oehler Daniel²,Tudorache Igor¹,Aubin Hug¹,Lichtenberg Artur¹,Boeken Udo¹

Affiliation:

1. Department of Cardiac Surgery Heinrich Heine University Düsseldorf Düsseldorf Germany

2. Department of Cardiology Heinrich Heine University Düsseldorf Düsseldorf Germany

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/iid3.508

Reference18 articles.

1. The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation

2. Cytomegalovirus Serology and Replication Remain Associated With Solid Organ Graft Rejection and Graft Loss in the Era of Prophylactic Treatment

3. Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials: Table 1.

4. Cytomegalovirus infection in heart transplant recipients is associated with impaired endothelial function;Petrakopoulou P;Circulation,2004

5. Cytomegalovirus infection and disease reduce 10-year cardiac allograft vasculopathy-free survival in heart transplant recipients

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update;Transplantation Reviews;2024-12

2. Immunopathology of lung transplantation: from infection to rejection and vice versa;Frontiers in Immunology;2024-09-02

3. Effect of CMV Mismatch on Heart Transplant Outcomes Using a Surveillance and Preemptive Strategy;Clinical Transplantation;2024-09

4. Evaluation of risk factors for cytomegalovirus DNAemia after end of regular prophylaxis after heart transplantation;Immunity, Inflammation and Disease;2023-11

5. Differential effects of CMV infection on the viability of cardiac cells;Cell Death Discovery;2023-04-03